Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.55 |
| ▸ | NPY1R | P25929 | 9/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.55 |
| ▸ | NPY2R | P49146 | 5/20 | 0.55 |
| ▸ | KISS1R | Q969F8 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31405541 | 0.94 | BACE1 (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30477221 | 0.93 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29641576 | 0.93 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL4456143 | 0.92 | BACE1 (0.59) | KISS1R | |
| SCHEMBL4456136 | 0.92 | BACE1 (0.59) | KISS1R | |
| SCHEMBL30541920 | 0.91 | GNPAT (0.52) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30575415 | 0.91 | NPY4R (0.46) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30198934 | 0.88 | BACE1 (0.52) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL29608079 | 0.87 | KISS1R (0.57) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30089310 | 0.87 | NPY4R (0.60) | NPY4RNPY1RNPY5RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11628202-B2 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia | NYMOX CORPORATION (CA) | 2023-04-18 | — | — | US | disclosed |